GATA2 finds its macrophage niche

Blood

Volumn 118, Issue 10, 2011, Pages 2647-2649

  Migliaccio, Anna Rita ^a   Bieker, James J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 2;

B LYMPHOCYTE; BONE MARROW; CELL EXPANSION; CELL MATURATION; DENDRITIC CELL; DNA BINDING; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HAPLOINSUFFICIENCY; HUMAN; IMMUNE DEFICIENCY; MACROPHAGE; MONOCYTE; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; NATURAL KILLER CELL; NOTE; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN INTERACTION; VIRUS INFECTION;

EID: 80052617770     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-362772     Document Type: Note

References (16)

1. Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the aurosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-2655.
2. Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B andNKlymphoid deficiency. Blood. 2011;118(10):2656-2658.
3. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132(4):631-644. (Pubitemid 351260057)
4. Lasbury ME, Tang X, Durant PJ, Lee CH. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect Immun. 2003;71(9):4943-4952. (Pubitemid 37070736)
5. Kitajima K, Tanaka M, Zheng J, et al. Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2. Blood. 2006;107(5):1857-1863. (Pubitemid 43289363)
6. Carotta S, Dakic A, D'Amico A, et al. The transcription factor PU. 1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity. 2010;32(5):628-641.
7. Cantor AB.GATAtranscription factors in hematologic disease. Int J Hematol. 2005;81(5):378-384.
8. Malinge S, Izraeli S, Crispino JD. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood. 2009;113(12):2619-2628.
9. Zhang SJ, Ma LY, Huang QH, et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad SciU S A. 2008;105(6):2076-2081.
10. Fujimaki S, Harigae H, Sugawara T, Takasawa N, Sasaki T, Kaku M. Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia. Br J Haematol. 2001;113(1):52-57. (Pubitemid 32423302)
11. Bonadies N, Foster SD, Chan WI, et al. Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia. PLoS One. 2011;6(1):e16330.
12. Snow JW, Trowbridge JJ, Johnson KD, et al. Contextdependent function of "GATA switch" sites in vivo. Blood. 2011;117(18):4769-4772.
13. Scott HS, Hahn CN, Carmichael CL, et al. GATA2 is a novel predisposition gene for familial myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) [abstract]. Blood (ASH Annual Meeting Abstracts). 2010; 116(21):Abstract 3.
14. Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B andNKlymphoid deficiency. J Exp Med. 2011;208(2):227-234.
15. Bresnick EH, Martowicz ML, Pal S, Johnson KD. Developmental control viaGATAfactor interplay at chromatin domains [review]. J Cell Physiol. 2005;205(1):1-9. (Pubitemid 41262845)
16. Varricchio L, Masselli E, Alfani E, et al. The dominant negative beta isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood. 2011;118(2):425-436.